+++Thanks_Inte_2 articles from Springer

[pendyala123]

1. Empagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
Drugs (2014), 74, (15), 1769-1784.

Код: Выделить всё

http://link.springer.com/article/10.1007%2Fs40265-014-0298-1

DOI:

http://dx.doi.org/10.​1007/​s40265-014-0336-z

2.Canagliflozin: First Global Approval
Drugs, June 2013, Volume 73, Issue 9, pp 979-988

Код: Выделить всё

http://link.springer.com/article/10.1007/s40265-013-0064-9

DOI:

http://dx.doi.org/​10.​1007/​s40265-013-0139-7

[Inte]

1st

[Inte]

2nd